The Lancet is a weekly peer-reviewed general medical journal. It is one of the world's best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three
A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial published today in The ...
Oct 16, 2020
1
524
The number of confirmed cases for the novel coronavirus disease COVID-19 officially issued by countries and widely reported by national and international media outlets dramatically understates the true number of infections, ...
Apr 7, 2020
3
9085
A review of adverse events following vaccination against COVID-19 with mRNA vaccines in the U.S. confirms that most side effects were mild and decreased substantially after one day. The new study, published in The Lancet ...
Mar 7, 2022
0
272
Researchers, led by the NIHR Oxford Biomedical Research Centre, the Health Protection Agency in Birmingham and the Wellcome Trust Sanger Institute in Cambridge, have pioneered the whole genome sequencing (WGS) method through ...
Nov 14, 2012
0
0
Middle-aged people, and not just the elderly, have a dramatically higher risk of dying or developing serious illness from COVID-19, new research from Britain showed Tuesday.
Mar 31, 2020
0
77
People with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against the virus, two new studies said on Friday.
Apr 1, 2022
0
207
A single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households, new research concludes.
Jul 13, 2020
0
222
Once infected with the new coronavirus, a 20-something has about a 1% chance of illness so severe it requires hospitalization, and that risk rises to more than 8% for people in their 50s and to nearly 19% for people over ...
Mar 31, 2020
0
13
Antibiotic-resistant E. coli is more likely to be spread through poor toilet hygiene than undercooked chicken or other food, according to new research from a consortium including the University of East Anglia.
Oct 22, 2019
1
4442
A Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate was shown to be safe, well-tolerated, and induced a robust immune response in a Phase 1 first-in-human clinical trial. Initial findings from the ...
Jul 25, 2019
0
3
